SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose Passive 4.9% Stake in Teradyne Inc.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.9% in Teradyne Inc.'s common stock as of March 31, 2025.

Summary

• FMR LLC and Abigail P. Johnson jointly filed an Amendment No. 5 to Schedule 13G regarding their beneficial ownership of Teradyne Inc. (CUSIP: 880770102) common stock.
• As of March 31, 2025, the aggregate amount beneficially owned by each reporting person is 7,910,777.01 shares.
• This represents 4.9% of the class of Teradyne Inc. common stock outstanding.
• FMR LLC holds sole voting power over 7,346,464.47 shares and sole dispositive power over 7,910,777.01 shares.
• Abigail P. Johnson holds sole dispositive power over 7,910,777.01 shares, with no sole or shared voting power.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Several FMR LLC subsidiaries, including FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC, are identified as entities beneficially owning shares.
• Abigail P. Johnson, as Director, Chairman, and CEO of FMR LLC, along with other Johnson family members, are predominant owners of FMR LLC's Series B voting common shares (49% voting power) and may be deemed to form a controlling group with respect to FMR LLC.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, providing no positive or negative operational or financial news for the issuer, Teradyne Inc. The sentiment is neutral as it simply reports a passive stake.

Positives

• FMR LLC, a major institutional investor, maintains a significant, albeit passive, stake in Teradyne Inc., indicating continued institutional interest in the company.

Negatives

• The reported beneficial ownership of 4.9% is below the 5% threshold, signifying a passive investment stance and no intent to influence control, which might be interpreted as a reduction from a previous higher stake (implied by Amendment No. 5, though not explicitly stated as a reduction).

Risks

• None mentioned related to Teradyne Inc.'s operations or financial health within this beneficial ownership report.

Future Outlook

This document does not contain any forward-looking statements or guidance regarding Teradyne Inc.'s future performance or outlook.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a routine disclosure of beneficial ownership by a large institutional investor and does not provide specific insights into broader industry trends or competitive dynamics for Teradyne Inc.

Related Party Transactions

• The filing details the relationship between FMR LLC and Abigail P. Johnson, noting that Johnson family members, including Abigail P. Johnson, are predominant owners of FMR LLC's Series B voting common shares and may form a controlling group with respect to FMR LLC.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's passive stake in the company.
• Management: Confirms that a major shareholder is not seeking to influence control of the company.

Key Dates

Keywords

Teradyne Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Passive Investment